Lam Research (LRCX) Down 4.5% Since Last Earnings Report: Can It Rebound?

22.11.24 17:31 Uhr

Werte in diesem Artikel
Aktien

730,70 EUR -61,10 EUR -7,72%

Indizes

21.289,2 PKT 178,7 PKT 0,85%

19.572,6 PKT 199,8 PKT 1,03%

1.854,4 PKT -8,4 PKT -0,45%

5.930,9 PKT 63,8 PKT 1,09%

A month has gone by since the last earnings report for Lam Research (LRCX). Shares have lost about 4.5% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Lam Research due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Lam Research Q1 Earnings & Revenues Beat EstimatesLam Research Corporation delivered first-quarter fiscal 2025 post-split non-GAAP earnings of 86 cents per share, which surpassed the Zacks Consensus Estimate of 80 cents. The figure increased 6.2% sequentially. Lam Research announced its decision of a 10-for-1 stock split on May 21, 2024. The stock split was made effective on Oct. 2, 2024, for shareholders of record at that time.Revenues of $4.17 billion surpassed the Zacks Consensus Estimate of $4.05 billion. The figure increased 7.6% quarter over quarter. The sequential growth in the top line was driven by the strong performance of the Customer Support Business Group and the rebound in the System business.LRCX’s Segment in DetailsLam Research’s System revenues were $2.4 billion (57.4% of the total revenues), up 10.3% from the previous quarter. System revenues grew 16.3% year over year. The reported figure missed the Zacks Consensus Estimate of $2.52 billion.In the Customer Support Business Group, revenues for the reported quarter were $1.78 billion (42.6% of the total revenues), up 4.3% from the previous quarter and 24.5% year over year. The figure beat the consensus mark of $1.53 billion.China, Korea and Taiwan accounted for 37%, 18% and 15% of Lam Research’s total revenues, respectively, for the fiscal first quarter. Japan, Southeast Asia, the United States and Europe accounted for 7%, 6%, 12% and 5% of total revenues, respectively.Operating Details of LRCXThe non-GAAP gross margin was 48.2%, which contracted 30 basis points (bps) from the previous quarter.Non-GAAP operating expenses were $722 million, up 4.8% from the previous quarter. As a percentage of revenues, the figure contracted 50 bps quarter over quarter to 17.3%.The non-GAAP operating margin was 30.9%, expanding 20 bps from the previous quarter’s 30.7%.LRCX’s Balance Sheet & Cash FlowAs of Sept. 29, 2024, cash and cash equivalents were $6.07 billion compared with $5.85 billion as of June 30, 2024.Cash flow from operating activities was $1.57 billion for the reported quarter, up from $862.43 million in the previous quarter.In the reported quarter, Lam Research paid out dividends of $261 million and repurchased shares worth $1 billion.LRCX Provides Strong GuidanceFor second-quarter fiscal 2025, LRCX now expects its revenues to be $4.30 billion (+/- $300 million), up from the previous guidance of $4.05 billion (+/- $300 million).The non-GAAP gross margin is projected at 47% (+/-1%), whereas the non-GAAP operating margin is expected to be 30% (+/-1%).Non-GAAP earnings per share are projected to be 87 cents (+/- 10 cents) on a diluted share count of 1.3 billion.How Have Estimates Been Moving Since Then?It turns out, fresh estimates have trended upward during the past month.VGM ScoresAt this time, Lam Research has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Following the exact same course, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Lam Research has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Lam Research

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Lam Research

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Lam Research Corp.

Analysen zu Lam Research Corp.

DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
29.10.2018Lam Research NeutralB. Riley FBR
DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
17.10.2018Lam Research OutperformCowen and Company, LLC
DatumRatingAnalyst
29.10.2018Lam Research NeutralB. Riley FBR
01.10.2018Lam Research HoldDeutsche Bank AG
01.10.2018Lam Research NeutralMizuho
12.10.2016Lam Research Sector WeightPacific Crest Securities Inc.
21.04.2015Lam Research Sector PerformRBC Capital Markets
DatumRatingAnalyst
22.10.2015Lam Research UnderperformRBC Capital Markets
05.10.2015Lam Research UnderperformRBC Capital Markets
11.11.2010Lam Research sellCitigroup Corp.
29.07.2010Lam Research sellCitigroup Corp.
19.03.2009Lam Research underperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"